MarketCap
Facebook
X
TelegramQuarterly report 2025-Q4
added 02-11-2026
Organovo Holdings Total Shareholders Equity 2011-2026 | ONVO
Annual Total Shareholders Equity Organovo Holdings
| 2025 | 2024 | 2023 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10.5 M | 364 K | 15.3 M | 39.2 M | 26.6 M | 36.3 M | 44.6 M | 62.4 M | 62.2 M | 48.7 M | 48.3 M | 8.97 M | -5.3 M | -1.84 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 62.4 M | -5.3 M | 28.3 M |
Quarterly Total Shareholders Equity Organovo Holdings
| 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4.44 M | 7.06 M | 9.54 M | 10.5 M | 364 K | 3.68 M | 6.66 M | 3.6 M | 6.18 M | 8.46 M | 11.8 M | 15.3 M | 22.3 M | 25 M | 27.7 M | 30.2 M | 31.3 M | 34.2 M | 37.3 M | 39.2 M | 20.8 M | 20 M | 24.8 M | 26.6 M | 29 M | 31.1 M | 36.1 M | 36.3 M | 35.7 M | 38.9 M | 41.4 M | 44.6 M | 48.6 M | 52.1 M | 57.3 M | 62.4 M | 70.9 M | 52.5 M | 54.8 M | 62.2 M | 69 M | 76.2 M | 85.3 M | 48.7 M | 48.3 M | 53.4 M | 43.8 M | 48.3 M | 48.7 M | 51.9 M | 6.91 M | 8.97 M | -5.3 M | -5.3 M | -5.3 M | -5.3 M | -1.84 M | -1.83 M | -1.83 M | -1.83 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 85.3 M | -5.3 M | 29 M |
Total Shareholders Equity of other stocks in the Diagnostics research industry
| Issuer | Total Shareholders Equity | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Enzo Biochem
ENZ
|
56.1 M | - | -8.98 % | $ 14.8 K |  USA |
 |
Centogene N.V.
CNTG
|
27.5 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Heska Corporation
HSKA
|
422 M | - | - | $ 1.31 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
7.17 B | $ 203.59 | -0.44 % | $ 22.6 B | USA |
 |
Celcuity
CELC
|
101 M | $ 88.87 | -4.02 % | $ 4.16 B | USA |
|
Akumin
AKU
|
-48.2 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Co-Diagnostics
CODX
|
20.6 M | $ 4.25 | -5.56 % | $ 5.65 M | USA |
 |
Castle Biosciences
CSTL
|
471 M | $ 21.19 | 0.52 % | $ 614 M | USA |
 |
Fulgent Genetics
FLGT
|
1.11 B | $ 19.02 | 2.84 % | $ 585 M | USA |
 |
Aspira Women's Health
AWH
|
-6.93 M | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
-56 M | - | -61.36 % | $ 2.46 M | USA |
 |
Biocept
BIOC
|
8.86 M | - | -13.05 % | $ 7.29 M | USA |
 |
ICON Public Limited Company
ICLR
|
9.19 B | $ 147.15 | -3.08 % | $ 11.5 B |  Irlanda |
 |
Guardant Health
GH
|
-99.3 M | $ 130.83 | 0.55 % | $ 16.4 B | USA |
 |
Illumina
ILMN
|
2.72 B | $ 164.1 | 2.54 % | $ 25.4 B | USA |
 |
CareDx, Inc
CDNA
|
303 M | $ 23.71 | 4.22 % | $ 1.26 B | USA |
 |
Chembio Diagnostics
CEMI
|
17.8 M | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
3.44 M | - | - | $ 9.42 M |  Israel |
 |
Interpace Biosciences
IDXG
|
22.4 M | $ 1.76 | 1.32 % | $ 7.79 M | USA |
 |
HTG Molecular Diagnostics
HTGM
|
5.39 M | - | -20.0 % | $ 1.06 M | USA |
 |
Global Cord Blood Corporation
CO
|
4.88 B | - | - | $ 399 M |  China |
 |
Genetic Technologies Limited
GENE
|
1.83 M | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
548 M | - | 0.12 % | $ 80.1 M | China |
 |
DermTech
DMTK
|
57.2 M | - | -11.32 % | $ 2.94 M | USA |
 |
Lantheus Holdings
LNTH
|
1.09 B | $ 101.96 | 1.98 % | $ 6.88 B | USA |
 |
Charles River Laboratories International
CRL
|
3.16 B | $ 187.54 | -1.29 % | $ 9.3 B | USA |
 |
Pacific Biosciences of California
PACB
|
5.35 M | $ 1.4 | 1.82 % | $ 420 M | USA |
 |
Medpace Holdings
MEDP
|
459 M | $ 470.7 | 0.84 % | $ 13.6 B | USA |
 |
Exact Sciences Corporation
EXAS
|
2.4 B | - | - | $ 19.8 B | USA |
 |
Mettler-Toledo International
MTD
|
-23.6 M | $ 1 132.35 | -2.63 % | $ 23.3 B |  Schweiz |
 |
NeoGenomics
NEO
|
837 M | $ 11.47 | 0.26 % | $ 1.47 B | USA |
 |
Myriad Genetics
MYGN
|
368 M | $ 4.59 | 0.99 % | $ 425 M | USA |
 |
National Research Corporation
NRC
|
14 M | $ 21.0 | 6.33 % | $ 470 M | USA |
 |
Natera
NTRA
|
1.71 B | $ 218.38 | -1.99 % | $ 29.9 B | USA |
 |
Personalis
PSNL
|
261 M | $ 9.74 | -0.1 % | $ 869 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
11 B | $ 25.77 | -2.77 % | $ 24.4 B |  Niderland |
 |
Senseonics Holdings
SENS
|
61 M | $ 7.22 | -2.83 % | $ 301 M | USA |
 |
QIAGEN N.V.
QGEN
|
3.78 B | - | - | $ 10.6 B | Niderland |
 |
Soleno Therapeutics
SLNO
|
450 M | - | - | $ 2.69 B | USA |
 |
Biomerica
BMRA
|
4.1 M | $ 2.03 | -1.02 % | $ 4.66 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
8.62 B | $ 268.15 | -1.12 % | $ 22.3 B | USA |
 |
Twist Bioscience Corporation
TWST
|
473 M | $ 68.37 | -2.41 % | $ 4.09 B | USA |
 |
Thermo Fisher Scientific
TMO
|
53.4 B | $ 482.91 | -2.31 % | $ 182 B | USA |
 |
Trinity Biotech plc
TRIB
|
-35.2 M | $ 0.68 | 2.39 % | $ 244 M | Irlanda |
 |
Motus GI Holdings
MOTS
|
2.69 M | - | -34.28 % | $ 263 K | Israel |
 |
Neogen Corporation
NEOG
|
2.07 B | $ 9.26 | -0.32 % | $ 2.01 B | USA |
 |
Invitae Corporation
NVTA
|
102 M | - | - | $ 21.2 M | USA |